Oct 23, 2006 |
Welcome to Jeff Krstich, CEO of International Stem Cell Corporation |
ISC welcomes Mr. Jeff Krstich - a strong new addition to its team. Mr. Krstich will take the role of CEO of International Stem Cell Corporation, a public company to be formed as a result of upcoming financings. Jeff will handle mergers and acquisitions and Wall Street relations.
Mr. Krstich has been a senior executive in the healthcare industry for over 28 years with experience in Biotech, Diagnostics, and Medical Device companies.
He was recently involved in recapitalization and sale of Pathology Partners Inc. to CARIS Ltd, and prior to that was President of MarketStar HealthCare a subsidiary of Omnicom (NYSE-OMC). As Director of Sales at Biogen (NASDQ-BIIB) he was instrumental in creating their fully integrated organization and growing revenues to over $600 million in four years. He has served as Area Vice President, Region Vice President, and Corporate Vice President with Baxter Healthcare (NYSE-BAX) working in the Hospital, Diagnostic, and Corporate Sales Divisions. His Healthcare career started with American Hospital Supply in General Management positions with the Hospital Supply and Hospitex divisions. A former Navy Test Pilot and veteran of Vietnam and Gulf Storm, he has an MBA and BS from the United States Naval Academy.
|
|
|
|
|